Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amylyx Pharmaceuticals (AMLX) Asset Utilization Ratio (2022 - 2025)

Amylyx Pharmaceuticals (AMLX) has 4 years of Asset Utilization Ratio data on record, last reported at 0.1 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 114.15% year-over-year to 0.1; the TTM value through Sep 2025 reached 0.1, down 114.15%, while the annual FY2024 figure was 0.25, 70.66% down from the prior year.
  • Asset Utilization Ratio reached 0.1 in Q3 2025 per AMLX's latest filing, up from 0.13 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.82 in Q1 2024 and bottomed at 0.13 in Q2 2025.
  • Average Asset Utilization Ratio over 4 years is 0.3, with a median of 0.27 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: surged 41658.64% in 2023, then tumbled 116.64% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.08 in 2022, then skyrocketed by 888.27% to 0.77 in 2023, then crashed by 63.23% to 0.28 in 2024, then plummeted by 133.88% to 0.1 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.1 in Q3 2025, 0.13 in Q2 2025, and 0.12 in Q1 2025.